Astera Labs, Inc. (NASDAQ:ALAB) Given Consensus Recommendation of “Moderate Buy” by Analysts

Shares of Astera Labs, Inc. (NASDAQ:ALAB) have earned an average rating of “Moderate Buy” from the twenty-two ratings firms that are covering the company, MarketBeat.com reports. Eight analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $184.8235.

Several analysts recently commented on the stock. Zacks Research downgraded shares of Astera Labs from a “strong-buy” rating to a “hold” rating in a research report on Monday, October 6th. TD Cowen decreased their price target on Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a research note on Wednesday, November 5th. Needham & Company LLC upped their target price on shares of Astera Labs from $205.00 to $220.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Jefferies Financial Group lifted their price target on Astera Labs from $95.00 to $130.00 and gave the stock a “buy” rating in a research note on Tuesday, July 22nd. Finally, Barclays reaffirmed an “equal weight” rating and issued a $155.00 target price on shares of Astera Labs in a research note on Monday, October 20th.

Insiders Place Their Bets

In other news, Director Jack R. Lazar sold 22,500 shares of the business’s stock in a transaction on Wednesday, August 27th. The shares were sold at an average price of $178.42, for a total transaction of $4,014,450.00. Following the completion of the sale, the director directly owned 97,351 shares of the company’s stock, valued at $17,369,365.42. The trade was a 18.77% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Manuel Alba sold 183,000 shares of the business’s stock in a transaction dated Tuesday, September 2nd. The stock was sold at an average price of $173.27, for a total value of $31,708,410.00. Following the sale, the director owned 385,863 shares of the company’s stock, valued at $66,858,482.01. The trade was a 32.17% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 225,500 shares of company stock valued at $39,531,460 over the last quarter. Company insiders own 12.50% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the stock. Assetmark Inc. boosted its holdings in shares of Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares during the period. Wexford Capital LP acquired a new stake in Astera Labs during the third quarter valued at approximately $39,000. National Bank of Canada FI boosted its position in shares of Astera Labs by 159.0% in the 3rd quarter. National Bank of Canada FI now owns 202 shares of the company’s stock valued at $39,000 after purchasing an additional 124 shares during the period. Pinpoint Asset Management Singapore Pte. Ltd. purchased a new position in Astera Labs during the 3rd quarter worth approximately $47,000. Finally, Whittier Trust Co. purchased a new position in Astera Labs during the 3rd quarter valued at about $55,000. 60.47% of the stock is owned by institutional investors and hedge funds.

Astera Labs Trading Down 2.0%

NASDAQ:ALAB opened at $141.39 on Tuesday. Astera Labs has a 12-month low of $47.13 and a 12-month high of $262.90. The firm has a market cap of $23.88 billion, a PE ratio of 127.38, a price-to-earnings-growth ratio of 2.69 and a beta of 1.38. The stock has a fifty day moving average price of $192.00 and a 200 day moving average price of $144.85.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $0.10. The company had revenue of $230.58 million for the quarter, compared to analysts’ expectations of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.Astera Labs’s quarterly revenue was up 103.9% on a year-over-year basis. During the same period last year, the firm earned $0.23 earnings per share. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. Equities analysts forecast that Astera Labs will post 0.34 EPS for the current year.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.